Ning Botao, Liang Lingfang, Lyu Yi, Yu Ying, Li Biru
Pediatric Intensive Care Unit, Shanghai Children's Medical Center affiliated with Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Pediatric Intensive Care Unit of Children's Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Transl Pediatr. 2020 Jun;9(3):213-220. doi: 10.21037/tp-19-178.
To investigate the effects of high-frequency oscillatory ventilation (HFOV) or airway pressure release ventilation (APRV) as a rescue therapy on children with moderate and severe acute respiratory distress syndrome (ARDS).
We retrospectively enrolled 47 children with ARDS who were transitioned from synchronized intermittent mandatory ventilation (SIMV) to either HFOV or APRV for 48 h or longer after failure of SIMV. The parameters of demographic data, arterial blood gases, ventilator settings, oxygenation index (OI), and PaO/FiO (PF) ratio during the first 48 h of HFOV and APRV were recorded.
There was no significant difference between the HFOV and APRV groups with survival rates of 60% and 72.7%, respectively. Compared to pre-transition, the mean airway pressures at 2 and 48 h after transition were higher in both groups (P<0.01), and the PF ratio at 2 and 48 h in both modes was significantly improved (P<0.001). PF ratio and PaCO have significant differences at 48 h between two groups. The OI at 2 h after transition had no improvement in either group and was substantially lower at 48 h relative to the pre-transition level (P<0.001) in both groups. At 48 h after the transition to both HFOV and APRV, the survivors had lower mean airway pressures, higher PF ratios, and a lower OIs than non-survivors (P<0.01).
There was no significant difference on the survival rates of HFOV and APRV application as a rescue therapy for ARDS, but improved oxygenation at 48 h reliably discriminated survivors from non-survivors in both groups.
探讨高频振荡通气(HFOV)或气道压力释放通气(APRV)作为挽救治疗对中重度急性呼吸窘迫综合征(ARDS)患儿的影响。
我们回顾性纳入了47例ARDS患儿,这些患儿在同步间歇指令通气(SIMV)失败后,从SIMV转换为HFOV或APRV并持续48小时或更长时间。记录了HFOV和APRV开始的前48小时内的人口统计学数据、动脉血气、呼吸机设置、氧合指数(OI)和动脉血氧分压/吸入氧分数(PaO/FiO,PF)比值等参数。
HFOV组和APRV组的生存率分别为60%和72.7%,两组之间无显著差异。与转换前相比,两组在转换后2小时和48小时的平均气道压力均升高(P<0.01),两种模式下2小时和48小时的PF比值均显著改善(P<0.001)。两组在48小时时的PF比值和动脉血二氧化碳分压(PaCO)有显著差异。转换后2小时两组的OI均无改善,且两组在48小时时相对于转换前水平均显著降低(P<0.001)。在转换至HFOV和APRV后48小时,存活者的平均气道压力较低,PF比值较高,OI低于非存活者(P<0.01)。
HFOV和APRV作为ARDS挽救治疗的应用在生存率上无显著差异,但48小时时氧合改善可可靠地区分两组中的存活者与非存活者。